Net Income (Loss) Per Common Share

6 Months Ended

May. 31, 2015

Earnings Per Share [Abstract]

Net Income (Loss) Per Common Share

Note 5 – Net Income (Loss) Per Common Share

Basic net income (loss) per share is computed by dividing net income available to common stockholders (numerator) by the weighted average number of vested, common shares outstanding during the period (denominator). Diluted net income (loss) per share is computed on the basis of the weighted average number of shares of common stock outstanding plus the effect of dilutive potential common shares outstanding during the period using the if-converted method. Dilutive potential common shares include shares issuable upon exercise of outstanding stock options, warrants and convertible debt agreements.

	Six Months Ended May 31, 2015			Six Months Ended May 31, 2014			Three Months Ended May 31, 2015			Three Months Ended May 31, 2014
Net income (loss) attributable to common stockholders - basic	$	(528,326	)	$	(372,151	)	$	1,461,656		$	(760,206	)
Income attributable to convertible notes								(1,413,320	)
Interest expense – convertible notes		—			—			270,490			—
Net income (loss) attributable to common stockholders - diluted	$	(528,326	)	$	(372,151	)	$	318,826		$	(760,206	)
Weighted average common shares outstanding - basic		2,448,541,449			946,116,664			3,231,962,508			1,007,499,997
Effect of dilutive securities		—			—			22,394,276,277			—
Weighted average common shares outstanding – diluted		2,448,541,449			946,116,664			25,626,238,785			1,007,499,997
Earnings (loss) per common share - basic	$	(0.00	)	$	(0.00	)	$	0.00		$	(0.00	)
Earnings (loss) per common share - diluted	$	(0.00	)	$	(0.00	)	$	0.00		$	(0.00	)

Approximately 1,224,948,000 and 1,204,948,000 shares of common stock issuable upon the exercise of outstanding stock options, warrants or convertible debt were excluded from the calculation of net income (loss) per share for the six and three-month periods ended May 31, 2015,respectively, because the effect would be anti-dilutive. Also excluded are shares of common stock issuable upon the conversion of our Series E, F, G, and H preferred for the six-month period ended May 31, 2015. At May 31, 2015, Series E and Series H preferred shares could convert into approximately 18,890,521,000 and and 2,361,315,130 shares of common stock, respectively. Series F and G preferred shares are not convertible at May 31, 2015. Approximately 1,475,706,000 and 1,485,708,000 shares of common stock issuable upon the exercise of outstanding stock options, warrants or convertible debt were excluded from the calculation of net income (loss) per share for the six and three-month periods ended May 31, 2014, respectively, because the effect would be anti-dilutive.